InvestorsHub Logo
Followers 39
Posts 6458
Boards Moderated 1
Alias Born 11/09/2019

Re: None

Friday, 10/14/2022 5:30:37 AM

Friday, October 14, 2022 5:30:37 AM

Post# of 255
Latest take. After several emails and calls, I've gotten zero response on either. Since April's announcement on exploring options, latent P2 trial results expected first quarter, and continual depreciating market cap despite 54 million in cash and tangibles, we're either near a major reversal or the end of the end. With the Gene therapy sector gaining interests and consolidation, LOGC of latest in consolidation, we will either a see a conclusion or capitulation.
Last post here..

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.